Seki N - Search Results

1

Efficacy of oral treatment with tacrolimus in the renal transplant model in cynomolgus monkeys.

Kinugasa F, Nagatomi I, Ishikawa H, Nakanishi T, Maeda M, Hirose J, Fukahori H, Ooshima S, Noto T, Higashi Y, Seki N, Mutoh S. Kinugasa F, et al. Among authors: seki n. J Pharmacol Sci. 2008 Dec;108(4):529-34. doi: 10.1254/jphs.08142fp. J Pharmacol Sci. 2008. PMID: 19098392 Free article.

2

Effect of the inosine 5'-monophosphate dehydrogenase inhibitor BMS-566419 on renal fibrosis in unilateral ureteral obstruction in rats.

Nakanishi T, Morokata T, Noto T, Kubo K, Umeno H, Kinugasa F, Eikyu Y, Kozuki Y, Seki N. Nakanishi T, et al. Among authors: seki n. Int Immunopharmacol. 2010 Nov;10(11):1434-9. doi: 10.1016/j.intimp.2010.08.011. Epub 2010 Sep 9. Int Immunopharmacol. 2010. PMID: 20832515

3

Effect of the inosine 5'-monophosphate dehydrogenase inhibitor BMS-566419 on rat cardiac allograft rejection.

Nakanishi T, Morokata T, Kubo K, Umeno H, Eikyu Y, Kozuki Y, Seki N. Nakanishi T, et al. Among authors: seki n. Int Immunopharmacol. 2010 Jan;10(1):91-7. doi: 10.1016/j.intimp.2009.09.026. Epub 2009 Oct 18. Int Immunopharmacol. 2010. PMID: 19840872

4

In vitro and in vivo characterization of AS2643361, a novel and highly potent inosine 5'-monophosphate dehydrogenase inhibitor.

Nakanishi T, Kozuki Y, Eikyu Y, Kubo K, Kawato Y, Marui T, Seki N, Masunaga T, Tamura K, Morokata T. Nakanishi T, et al. Among authors: seki n. Eur J Pharmacol. 2012 Jan 5;674(1):58-63. doi: 10.1016/j.ejphar.2011.10.032. Epub 2011 Oct 31. Eur J Pharmacol. 2012. PMID: 22075081

5

Alleviating effects of AS1892802, a Rho kinase inhibitor, on osteoarthritic disorders in rodents.

Takeshita N, Yoshimi E, Hatori C, Kumakura F, Seki N, Shimizu Y. Takeshita N, et al. Among authors: seki n. J Pharmacol Sci. 2011;115(4):481-9. doi: 10.1254/jphs.10319fp. Epub 2011 Feb 16. J Pharmacol Sci. 2011. PMID: 21325780 Free article.

6

Anti-inflammatory activity of non-nucleoside adenosine deaminase inhibitor FR234938.

Kuno M, Seki N, Tsujimoto S, Nakanishi I, Kinoshita T, Nakamura K, Terasaka T, Nishio N, Sato A, Fujii T. Kuno M, et al. Among authors: seki n. Eur J Pharmacol. 2006 Mar 18;534(1-3):241-9. doi: 10.1016/j.ejphar.2006.01.042. Epub 2006 Mar 3. Eur J Pharmacol. 2006. PMID: 16515782

7

Structure-based de novo design of non-nucleoside adenosine deaminase inhibitors.

Terasaka T, Nakanishi I, Nakamura K, Eikyu Y, Kinoshita T, Nishio N, Sato A, Kuno M, Seki N, Sakane K. Terasaka T, et al. Among authors: seki n. Bioorg Med Chem Lett. 2003 Mar 24;13(6):1115-8. doi: 10.1016/s0960-894x(03)00026-x. Bioorg Med Chem Lett. 2003. PMID: 12643924

8

Effect of auranofin on autoimmune disease in a mouse model.

Fujitsu T, Sakuma S, Seki N, Senoh H, Mori J, Kikuchi H. Fujitsu T, et al. Among authors: seki n. Int J Immunopharmacol. 1986;8(8):897-910. doi: 10.1016/0192-0561(86)90091-3. Int J Immunopharmacol. 1986. PMID: 3492451

9

Structure-based design and synthesis of non-nucleoside, potent, and orally bioavailable adenosine deaminase inhibitors.

Terasaka T, Okumura H, Tsuji K, Kato T, Nakanishi I, Kinoshita T, Kato Y, Kuno M, Seki N, Naoe Y, Inoue T, Tanaka K, Nakamura K. Terasaka T, et al. Among authors: seki n. J Med Chem. 2004 May 20;47(11):2728-31. doi: 10.1021/jm0499559. J Med Chem. 2004. PMID: 15139750

10

Structure-based design, synthesis, and structure-activity relationship studies of novel non-nucleoside adenosine deaminase inhibitors.

Terasaka T, Kinoshita T, Kuno M, Seki N, Tanaka K, Nakanishi I. Terasaka T, et al. Among authors: seki n. J Med Chem. 2004 Jul 15;47(15):3730-43. doi: 10.1021/jm0306374. J Med Chem. 2004. PMID: 15239652

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,075 results

Search Page

Filters